1 recruiting, 1 terminated, 1 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Prolactin-Producing Pituitary Tumor: new trials by email Literature Review of Prolactin-Producing Pituitary Tumor trials Research Report on Prolactin-Producing Pituitary Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Pasireotide in People With Prolactinoma Pasireotide, SF-36 and HADS - Prolactin-Producing Pituitary Tumor | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 10 | 2024-02-27 | 2026-03-04 |
| Validation of a Quality of Life Metric "Prolac-10" Prolactinoma, Prolactin-Producing Pituitary Tumor | Terminated | Ohio State University | 8 | 2019-10-15 | 2025-12-05 | |
| PRolaCT - Three Prolactinoma RCTs Endoscopic trans-sphenoidal adenoma resection, Dopamine Agonists - Prolactinoma, Prolactin-Producing Pituitary Tumor | Phase 4 | Unknown | Leiden University Medical Center | 880 | 2019-06-21 | 2020-07-20 |
Prolactinoma (2) · Pituitary Neoplasms (1)
Adenoma (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Hypothalamic Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Nervous System Diseases (2) · Pituitary Diseases (2) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Hypothalamic Neoplasms (1)
4-amino-4'-hydroxylaminodiphenylsulfone (1) · Dopamine Agonists (1) · Standard of Care (1) · pasireotide (1)
Leiden University Medical Center (1) · Memorial Sloan Kettering Cancer Center (1) · Ohio State University (1)
United States (2) · Netherlands (1)
Douglas Hardesty, MD (1) · Eliza Geer, MD (1) · Nienke R Biermasz, MD, prof. (1) · Wouter R van Furth, MD, PhD (1)